Timeline
Regeneron
US biotech that developed Inmazeb, the Zaire ebolavirus monoclonal cocktail with no approved Bundibugyo efficacy.
1 of 1 entries (1 events, 0 interactions)
Filters
#317 May
US biotech that developed Inmazeb, the Zaire ebolavirus monoclonal cocktail with no approved Bundibugyo efficacy.
1 of 1 entries (1 events, 0 interactions)